# Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients

> **NCT01786161** · PHASE4 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 44 (actual)

## Conditions studied

- MRSA - Methicillin Resistant Staphylococcus Aureus Infection

## Interventions

- **DRUG:** Vancomycin continuous infusion
- **DRUG:** Vancomycin intermittent dosing interval

## Key facts

- **NCT ID:** NCT01786161
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** slow recruitment
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01786161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01786161, "Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01786161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*